Synthesis of Rigid Receptors Based on Triphenylene Ketals
FULL PAPER
3 H, CH), 4.58 (br. s, 3 H, NHprox), 4.66 (d, JNH,H = 5.6 Hz, 3 H,
Cq). GC-MS (EI+): m/z (%) = 298 (55) [M – CH3]+, 270 (100) [M –
3
HNCO]+, 243 (36) [Ph3C]+.
NHdist), 6.76, 7.05 (2×d, J12,13 = 8.4 Hz, 6 H, phenyl-H), 7.69,
3
7.85 (2×s, 2×3 H, triphenylene-H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 20.9, 21.0 (bicyclo-CH2), 23.5 (CH3), 28.2, 28.3, 34.1,
34.2 (bicyclo-CH2), 38.2 (bicyclo-CH), 50.1 (CH), 57.9 (bicyclo-
Cq), 101.8, 102.0 (triphenylene-CH), 120.5 (C–Br), 121.9 (bicyclo-
OCO), 124.5, 124.6 (triphenylene-Cq), 127.3, 131.5 (phenyl-CH),
143.2 (phenyl-Cq), 147.4, 147.6 (triphenylene-CO), 156.7
(CO) ppm. MS (ES+): m/z (int.) = 1407.4 (11), 1408.4 (9), 1409.4
(11), 1410.4 (9), 1411.4 (5) [M + H]+, 1427.4 (25), 1428.4 (22),
1429.4 (85), 1430.4 (66), 1431.4 (100), 1432.4 (58), 1433.4 (48),
1434.4 (31), 1435.4 (11) [M + Na]+, 1443.4 (16), 1444.4 (11), 1445.4
(51), 1446.4 (40), 1447.4 (65), 1448.4 (43), 1449.4 (38), 1450.4 (20),
Trityl-Modified Subunit 32: 2-Methyl-3,3,3-triphenylpropionic acid
(30, 486 mg, 1.53 mmol) was dissolved in toluene (10 mL), concen-
trated under reduced pressure (3×), and then well dried in vacuo.
The anhydrous acid was dissolved in toluene (20 mL) by gentle
warming. After addition of triethylamine (0.32 mL, 233 mg,
2.30 mmol) and diphenylphosphoryl azide (507 mg, 1.84 mmol) at
ambient temperature and stirring for 15 min., the mixture was
heated at reflux until gas evaporation was no longer observed (2–
3 h) and was then allowed to cool to ambient temperature before
being chilled to 0 °C. Compound 18 (250 mg, 1.02 mmol), and af-
terwards triethylamine (0.14 mL, 103 mg, 1.02 mmol), were added,
and the mixture was stirred for 14 d at ambient temperature. After
fractionation between ethyl acetate (50 mL) and water (75 mL) the
aqueous phase was extracted with ethyl acetate (3×30 mL). The
combined organic layers were washed with brine (2×30 mL), dried
(MgSO4), and concentrated under reduced pressure. Purification
was performed by column chromatography (toluene/ethyl acetate,
9:1 Ǟ 8:2), yielding a colorless solid (510 mg, 0.91 mmol, 89%).
20
20
20
1451.4 (8) [M + K]+. [α] = +44.1, [α] = +46.9, [α] = +53.8,
589
578
546
20
[α] = +96.5 (c = 0.54, CH2Cl2). C72H75Br3N6O9·2EtOAc·PhCH3
436
(1676.46): calcd. C 62.33, H 5.95, N 5.01; found C 62.35, H 5.91,
N 5.21.
(+)-Tetralyl-Substituted Receptor 19c: The compound was obtained
as a gray solid (262 mg, 0.21 mmol, 38%) from all-syn trisamine 14
(400 mg, 0.55 mmol), triethylamine (0.23 mL, 167 mg, 1.65 mmol),
and (+)-(1S)-1,2,3,4-tetrahydronaphthyl isocyanate (22, 372 mg,
1.64 mmol), stirring for 7 d and purification by column chromatog-
raphy (cyclohexane/ethyl acetate, 8.2 Ǟ 6:4). M.p. 240 °C (de-
comp.). RF = 0.20 (cyclohexane/ethyl acetate, 8:2). 1H NMR
(400 MHz, CDCl3): δ = 1.37 (br. s, 12 H, tetralin-CH2), 1.65–1.67,
2.00–2.24 (m, 33 H, bicyclo-H), 2.33 (br. s, 6 H, tetralin-CH2), 2.84
(br. s, 6 H, bicyclo-H), 4.36–4.54 (m, 9 H, tetralin-CHNH and
1
M.p. 107 °C (decomp.). RF = 0.58 (toluene/ethyl acetate, 8:2). H
3
NMR (400 MHz, CDCl3): δ = 0.90 (d, JH,H = 6.4 Hz, 3 H, CH3),
1.49–1.54, 1.60–1.66, 1.91–2.14 (3×m, 11 H, bicyclo-CH2), 2.20
(br. s, 1 H, bicyclo-CH), 2.38–2.41 (m, 1 H, bicyclo-CH2), 4.14 (br.
3
s, 1 H, NHprox), 4.52 (d, JH,H = 10.0 Hz, 1 H, NHdist), 5.54–5.58
(m, 1 H, CH), 6.25 (d (b), 3JH,H = 7.6 Hz, 1 H, catechol-CH); 6.62–
6.75 (m, 3 H, catechol-CH); 7.21–7.35 (m, 15 H, trityl-H) ppm. 13
C
3
NH), 6.61 (d, JH,H = 7.6 Hz, 3 H, tetralin-CarH), 6.66, 6.79 (2×t,
NMR (100 MHz, CDCl3): δ = 18.6 (CH3), 21.1, 21.1, 27.9, 28.0,
32.9, 36.0 (bicyclo-CH2); 38.3 (bicyclo-CH), 48.0 (CH), 57.7 (bicy-
clo-Cq), 61.7 (CPh3), 108.6, 108.6 (catechol-CH), 120.7 (bicyclo-
OCO), 120.9, 121.5 (catechol-CH), 126.0, 126.0, 127.8 (trityl-C),
146.4, 147.3 (catechol-Cq), 156.7 (CO) ppm. MS (MALDI, DHB
matrix): m/z = 559, 560 [M + H]+, 581, 582 [M + Na]+, 597, 598
[M + K]+. (C37H38N2O3)2·H2O (1135.43): calcd. C 78.28, H 6.92,
N 4.83; found C 78.23, H 7.18, N 4.40. HRMS: calcd. for
3
3
3JH,H = 7.2, JH,H = 7.6 Hz, 2×3 H, tetralin-CarH), 6.85 (d, JH,H
= 7.6 Hz, 3 H, tetralin-CarH), 7.63 (br. s, 6 H, triphenylene-
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 19.8 (tetralin-CH2),
21.1, 28.3 (bicyclo-CH2), 29.1, 30.4 (tetralin-CH2), 34.5, 34.6 (bicy-
clo-CH2), 38.3 (bicyclo-CH), 48.0 (tetralin-CHNH), 58.0 (bicyclo-
Cq), 101.6, 101.6 (triphenylene-CH), 121.9 (bicyclo-OCO), 124.6
(triphenylene-Cq), 125.7, 126.6, 128.5, 128.7 (tetralin-CHarom),
137.1, 137.3 (tetralin-Cq), 147.4, 147.4 (triphenylene-CO), 156.9
(CO) ppm. MS (ES+): m/z (int.) = 1271.8 (100), 1272.8 (93), 1273.8
(40), 1274.8 (15), 1275.7 (5) [M + Na]+, 1287.8 (5), 1288.8 (5) [M
[C37H38N2O3
581.2790.
+
H+/Na+] 559.2961/581.2780; found 559.2964/
General Procedure for Synthesis of Optically Pure Receptors (19a–
19h): The all-syn trisamine 14 (1 equiv.) was dissolved in dichloro-
methane (20 mL) and chilled to 0 °C. After addition of triethyl-
amine (3 equiv.) and α-chiral isocyanate (6 equiv.) the reaction mix-
ture was allowed to warm to ambient temperature, stirred for the
given time, and then diluted with ethyl acetate (50 mL) and hydro-
chloric acid (0.2 m, 75 mL). The aqueous phase was extracted with
ethyl acetate (3×75 mL) and the combined organic layers were
washed with brine (2×50 mL), dried (MgSO4), and concentrated
in vacuo. The crude product was purified by column chromatog-
raphy or by crystallization from methanol or ethanol and sub-
sequently dried in high vacuum.
+ K]+. [α] = +40.2, [α] = +42.8, [α] = +49.8, [α] = +104.9
20
20
20
20
589
578
546
436
(c = 0.22, CH2Cl2). (C78H84N6O9)2·2EtOAc·H2O (2693.30): calcd.
C 73.14, H 6.96, N 6.24; found C 73.06, H 6.69, N 6.12.
(+)-(1R,3R,4S)-8-Phenylmenthyl-Substituted Receptor 19h: This
compound was obtained as
a light yellow solid (895 mg,
0.60 mmol, 87%) from all-syn trisamine 14 (500 mg, 0.69 mmol),
triethylamine (0.30 mL, 208 mg, 2.06 mmol), and (–)-(1R,3R,4S)-
8-phenylmenthyl isocyanate (27) (1.06 g, 4.11 mmol), stirring for
8 d, and purification by column chromatography (cyclohexane/
ethyl acetate, 9:1 Ǟ 6:4). M.p. 225 °C (decomp.). RF = 0.27 (cyclo-
1
hexane/ethyl acetate, 7:3). H NMR (400 MHz, CDCl3): δ = 0.40–
3
0.49 (m, 3 H, 14-Ha), 0.68 (d, J15,13 = 6.4 Hz, 9 H, 15-H,), 0.73–
Compounds 19a, 19e, 19f, and 19g are partially known, so their
complete sets of data are given in the Supporting Information (for
Supporting Information see also the footnote on the first page of
this article).
0.83 (m, 3 H, 12-Ha), 0.99 (s, 9 H, 21-/22-H), 1.04–1.08 (m, 3 H,
11-Ha), 1.14 (s, 9 H, 21-/22-H), 1.27–1.36 (m, 3 H, 13-Ha), 1.51–
1.65 (m, 18 H, of which 12 H: bicyclo-CH2 and 6H: 10-Ha, 12-He),
1.77–1.83 (m, 6 H, 11-He, 14-He), 1.96–2.23 (m, 21 H, bicyclo-H),
(+)-(1S)-4-Bromophenethyl-Substituted Receptor 19b: Compound
19b was obtained as a gray solid (348 mg, 0.25 mmol, 92%) from 3.38 (m, 6 H, NH), 6.49 (t, J20,19 = 7.2 Hz, 3 H, 20-H), 6.98 (t,
2.67–2.69 (m, 3 H, 9-Ha), 2.91–2.93 (m, 6 H, bicyclo-CH2), 3.33–
3
3
all-syn trisamine 14 (200 mg, 0.27 mmol), triethylamine (0.12 mL,
83 mg, 0.82 mmol), and (+)-(1S)-1-(4-bromophenyl)ethyl isocya-
nate (21, 372 mg, 1.64 mmol) after stirring for 3 d and purification
by column chromatography (toluene/ethyl acetate, 6:4). M.p.
3J19,18/20 = 7.6 Hz, 6 H, 19-H), 7.11 (d, J18,19 = 7.6 Hz, 6 H, 18-
H), 7.84, 7.89 (2×s, 2×3 H, triphenylene-H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 20.5 (C-21/-22), 20.9, 21.1 (bicyclo-CH2),
21.8 (C-15), 27.1 (C-11), 28.4, 28.5 (bicyclo-CH2), 31.0 (C-13), 31.6
(C-21/-22), 34.0 (bicyclo-CH2), 34.8 (C-12), 35.2 (bicyclo-CH2),
37.8 (bicyclo-CH), 39.4 (C-16), 44.7 (C-14), 51.4 (C-10), 51.8 (C-9),
57.1 (bicyclo-Cq), 101.9, 102.0 (triphenylene-CH), 121.9 (bicyclo-
1
185 °C (decomp.). RF = 0.16 (toluene/ethyl acetate, 6:4). H NMR
3
(400 MHz, CDCl3): δ = 1.10 (d, JH,H = 6.8 Hz, 9 H, CH3), 1.66–
1.71, 1.98–2.29, 2.86–2.91 (3×m, 39 H, bicyclo-H), 4.36–4.39 (m,
Eur. J. Org. Chem. 2005, 2987–2999
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2997